Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study

Addition of perindopril to CCB in stable CAD patients had a significant supplementary impact on cardiac outcomes and mortality.